Advisors Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.9M | Buy |
173,461
+8,776
| +5% | +$1.01M | 0.24% | 127 |
|
|
2025
Q4 | $17.3M | Buy |
164,685
+11,121
| +7% | +$1.04M | 0.2% | 131 |
|
|
2025
Q3 | $12.9M | Buy |
153,564
+7,654
| +5% | +$630K | 0.16% | 148 |
|
|
2025
Q2 | $11.6M | Buy |
145,910
+13,036
| +10% | +$1.04M | 0.16% | 143 |
|
|
2025
Q1 | $11.9M | Buy |
132,874
+13,867
| +12% | +$1.29M | 0.18% | 135 |
|
|
2024
Q4 | $11.8M | Sell |
119,007
-5,163
| -4% | -$532K | 0.19% | 133 |
|
|
2024
Q3 | $14.1M | Buy |
124,170
+45,586
| +58% | +$5.42M | 0.23% | 125 |
|
|
2024
Q2 | $9.73M | Buy |
78,584
+2,855
| +4% | +$368K | 0.17% | 138 |
|
|
2024
Q1 | $9.99M | Buy |
75,729
+5,966
| +9% | +$735K | 0.18% | 137 |
|
|
2023
Q4 | $7.61M | Buy |
69,763
+822
| +1% | +$85.3K | 0.15% | 143 |
|
|
2023
Q3 | $7.1M | Buy |
68,941
+1,469
| +2% | +$158K | 0.18% | 130 |
|
|
2023
Q2 | $7.79M | Buy |
67,472
+12,545
| +23% | +$1.42M | 0.19% | 132 |
|
|
2023
Q1 | $5.84M | Sell |
54,927
-980
| -2% | -$106K | 0.15% | 140 |
|
|
2022
Q4 | $6.2M | Buy |
55,907
+2,464
| +5% | +$252K | 0.17% | 131 |
|
|
2022
Q3 | $5.36M | Buy |
53,443
+1,907
| +4% | +$170K | 0.14% | 141 |
|
|
2022
Q2 | $4.7M | Buy |
51,536
+2,080
| +4% | +$184K | 0.14% | 144 |
|
|
2022
Q1 | $4.06M | Sell |
49,456
-258,835
| -84% | -$20.4M | 0.11% | 166 |
|
|
2021
Q4 | $23.6M | Buy |
308,291
+12,702
| +4% | +$1.01M | 0.64% | 52 |
|
|
2021
Q3 | $22.2M | Buy |
295,589
+13,689
| +5% | +$1.04M | 0.68% | 48 |
|
|
2021
Q2 | $21.9M | Sell |
281,900
-2,680
| -0.9% | -$199K | 0.7% | 49 |
|
|
2021
Q1 | $20.9M | Sell |
284,580
-157,954
| -36% | -$11.7M | 0.73% | 47 |
|
|
2020
Q4 | $34.5M | Buy |
442,534
+27,459
| +7% | +$2.1M | 1.32% | 12 |
|
|
2020
Q3 | $32.9M | Buy |
415,075
+13,198
| +3% | +$1.03M | 1.53% | 8 |
|
|
2020
Q2 | $29.7M | Buy |
401,877
+52,879
| +15% | +$3.98M | 1.47% | 10 |
|
|
2020
Q1 | $25.6M | Buy |
348,998
+226,817
| +186% | +$17.8M | 1.63% | 12 |
|
|
2019
Q4 | $10.6M | Buy |
122,181
+30,573
| +33% | +$2.51M | 0.5% | 74 |
|
|
2019
Q3 | $7.36M | Buy |
91,608
+13,575
| +17% | +$1.09M | 0.4% | 81 |
|
|
2019
Q2 | $6.24M | Buy |
78,033
+6,289
| +9% | +$482K | 0.37% | 85 |
|
|
2019
Q1 | $5.7M | Buy |
71,744
+3,471
| +5% | +$260K | 0.36% | 88 |
|
|
2018
Q4 | $4.98M | Sell |
68,273
-37,856
| -36% | -$2.67M | 0.36% | 84 |
|
|
2018
Q3 | $7.18M | Buy |
106,129
+7,770
| +8% | +$495K | 0.47% | 71 |
|
|
2018
Q2 | $5.7M | Buy |
+98,359
| New | +$5.55M | 0.39% | 81 |
|
Other funds holding MRK
VCM
VPM
Advisors Capital Management's MRK Position: Q1 2026 in Review
Advisors Capital Management increased its Merck (MRK) stake by 5.3% in Q1 2026, buying an estimated $1.01M and bringing the position to 173,461 shares worth $20.9M. The position accounts for 0.24% of the portfolio, ranked #127.
Advisors Capital Management first reported a position in MRK in Q2 2018 and has held it in 32 quarters since. The position peaked at $34.5M in Q4 2020. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Advisors Capital Management held 173,461 shares of Merck worth $20.9M as of Q1 2026.
- Advisors Capital Management bought 8,776 Merck shares in Q1 2026, an estimated $1.01M.
- Merck made up 0.24% of Advisors Capital Management's portfolio in Q1 2026, its #127 holding.
- Advisors Capital Management first reported a position in Merck in Q2 2018 and has held it in 32 quarters since.
- Advisors Capital Management's Merck position peaked at $34.5M in Q4 2020.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Advisors Capital Management's 13F filing for Q1 2026, filed 1 May 2026.